Tall Man lettering

Last updated
A vial of Dopamine, labeled as "DOPamine HCl" Dopamine HCl.JPG
A vial of Dopamine, labeled as "DOPamine HCl"

Tall man lettering (tall-man lettering or tallman lettering) is the practice of writing part of a drug's name in upper case letters to help distinguish sound-alike, look-alike drugs from one another in order to avoid medication errors. [1] [2] For example, in tall man lettering, "prednisone" and "prednisolone" should be written "predniSONE" and "predniSOLONE", respectively. The Office of Generic Drugs of the US Food and Drug Administration (FDA) encourages manufacturers to use tall man lettering labels to visually differentiate their drugs' names, [1] and a number of hospitals, clinics, and health care systems use tall man lettering in their computerized order entry, automated dispensing machines, medication admission records, prescription labels, and drug product labels. [3]

Contents

Effectiveness

Wrong-drug errors have been found to occur at a rate of about one per thousand orders filled or dispensed. [4] Evidence regarding the effect of Tall Man lettering on error rates is mixed.

A 2004 eye-tracking study found that Tall Man lettering resulted in fewer errors when selecting a target drug from an array of choices. [5] Other laboratory-based studies of Tall Man lettering show a mixture of positive and null results, which may be further complicated due to demand characteristics of some of the studies. [4]

A 2016 time-series analysis of data from 42 children's hospitals over a 9-year period found no significant difference before and after a 2007 recommendation for hospitals to adopt Tall Man lettering. [6] However, this study has been criticized due to methodological limitations, such as not recording when and how Tall Man lettering was adopted, if at all, at each of the hospitals studied. [4]

Examples

The FDA published a list [7] :Table 1 of recommended Tall-Man Letters for look-alike drugs which includes, but is not limited to:

The Institute for Safe Medication Practices (ISMP) has a supplemental list covering pairs not recommended by the FDA, but considered necessary by the ISMP. [7] :Table 2 ISMP Canada also offers additional recommendations. [8]

See also

Related Research Articles

<span class="mw-page-title-main">Food and Drug Administration</span> Agency of the US Department of Health and Human Services

The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.

<span class="mw-page-title-main">Over-the-counter drug</span> Medication available without a prescription

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) rather than final products. By regulating APIs instead of specific drug formulations, governments allow manufacturers the freedom to formulate ingredients, or combinations of ingredients, into proprietary mixtures.

In the metric system, a microgram or microgramme is a unit of mass equal to one millionth of a gram. The unit symbol is μg according to the International System of Units (SI); the recommended symbol in the United States and United Kingdom when communicating medical information is mcg. In μg the prefix symbol for micro- is the Greek letter μ (mu).

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that legally requires a medical prescription to be dispensed. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

A medical error is a preventable adverse effect of care ("iatrogenesis"), whether or not it is evident or harmful to the patient. This might include an inaccurate or incomplete diagnosis or treatment of a disease, injury, syndrome, behavior, infection, or other ailment.

<span class="mw-page-title-main">Off-label use</span> Use of pharmaceuticals for conditions different from that for which they were approved

Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration. Both prescription drugs and over-the-counter drugs (OTCs) can be used in off-label ways, although most studies of off-label use focus on prescription drugs.

Tall Man may refer to:

<span class="mw-page-title-main">Peter Piper</span> Nursery rhyme

"Peter Piper" is an English-language nursery rhyme and well-known alliteration tongue-twister. It has a Roud Folk Song Index number of 19745.

A Patient Safety Organization (PSO) is a group, institution, or association that improves medical care by reducing medical errors. Common functions of patient safety organizations are data collection and analysis, reporting, education, funding, and advocacy. A PSO differs from a Federally designed Patient Safety Organization (PSO), which provides health care providers in the U.S. privilege and confidentiality protections for efforts to improve patient safety and the quality of patient care delivery

<span class="mw-page-title-main">Medication package insert</span> Document included in a package of medicine

A package insert is a document included in the package of a medication that provides information about that drug and its use. For prescription medications, the insert is technical, providing information for medical professionals about how to prescribe the drug. Package inserts for prescription drugs often include a separate document called a "patient package insert" with information written in plain language intended for the end-user—the person who will take the drug or give the drug to another person, such as a minor. Inserts for over-the-counter medications are also written plainly.

<span class="mw-page-title-main">Compounding</span>

In the field of pharmacy, compounding is preparation of a custom formulation of a medication to fit a unique need of a patient that cannot be met with commercially available products. This may be done for medical reasons, such as administration in a different format, to avoid a non-active ingredient the patient is allergic to, or to provide an exact dose that isn't commercially available. Medically necessary compounding is referred to as "traditional" compounding. It may also be done for medically optional reasons, such as preference of flavor or texture, or dietary restrictions.

In medicine, an indication is a valid reason to use a certain test, medication, procedure, or surgery. There can be multiple indications to use a procedure or medication. An indication can commonly be confused with the term diagnosis. A diagnosis is the assessment that a particular [medical] condition is present while an indication is a reason for use. The opposite of an indication is a contraindication, a reason to withhold a certain medical treatment because the risks of treatment clearly outweigh the benefits.

Health information technology (HIT) is health technology, particularly information technology, applied to health and health care. It supports health information management across computerized systems and the secure exchange of health information between consumers, providers, payers, and quality monitors. Based on a 2008 report on a small series of studies conducted at four sites that provide ambulatory care – three U.S. medical centers and one in the Netherlands, the use of electronic health records (EHRs) was viewed as the most promising tool for improving the overall quality, safety and efficiency of the health delivery system.

<span class="mw-page-title-main">Bar code medication administration</span>

Bar code medication administration (BCMA) is a bar code system designed by Glenna Sue Kinnick to prevent medication errors in healthcare settings and to improve the quality and safety of medication administration. The overall goals of BCMA are to improve accuracy, prevent errors, and generate online records of medication administration.

Michael Cohen is an American pharmacist, and president of the Institute for Safe Medication Practices (ISMP). He was a 2005 MacArthur Fellow.

Barcode technology in healthcare is the use of optical machine-readable representation of data in a hospital or healthcare setting.

<span class="mw-page-title-main">Drug labelling</span>

Drug labelling is also referred to as prescription labelling, is a written, printed or graphic matter upon any drugs or any of its container, or accompanying such a drug. Drug labels seek to identify drug contents and to state specific instructions or warnings for administration, storage and disposal. Since 1800s, legislation has been advocated to stipulate the formats of drug labelling due to the demand for an equitable trading platform, the need of identification of toxins and the awareness of public health. Variations in healthcare system, drug incidents and commercial utilization may attribute to different regional or national drug label requirements. Despite the advancement in drug labelling, medication errors are partly associated with undesirable drug label formatting.

The Institute for Safe Medication Practices (ISMP) is an American 501(c)(3) organization focusing on the prevention of medication errors and promoting safe medication practices. It is affiliated with the ECRI Institute.

References

  1. 1 2 "Name Differentiation Project". FDA.gov. Center for Drug Evaluation and Research, U.S. Food and Drug Administration. Archived from the original on February 21, 2008. Retrieved January 10, 2022.
  2. "FAQ: 5. How should Tallman lettering be applied to look-alike/sound-alike drug name pairs?". ISMP.org. Institute for Safe Medication Practices. Archived from the original on December 18, 2007. Retrieved January 10, 2022.
  3. Examples: "University of Utah Health Care Pharmacy Alert #191" dated 2006/12/04, browsed 2007/12/20; Fraser Health 'Doctors in the Know' newsletter dated September, 2006, browsed 2007/12/20; Johns Hopkins Hospital "Pharmacy and Therapeutics Newsletter" dated July 2005, archived 2007/3/15.
  4. 1 2 3 Lambert, Bruce L; Schroeder, Scott R; Galanter, William L (2016). "Does Tall Man lettering prevent drug name confusion errors? Incomplete and conflicting evidence suggest need for definitive study". Editorial. BMJ Quality & Safety . 25 (4): 213–217. doi: 10.1136/bmjqs-2015-004929 . PMID   26700541.
  5. Filik, R; Purdy, K; Gale, A; Gerrett, D (December 2004). "Drug name confusion: Evaluating the effectiveness of capital ("Tall Man") letters using eye movement data". Social Science & Medicine . 59 (12): 2597–601. doi:10.1016/j.socscimed.2004.04.008. PMID   15474212.
  6. Zhong, Wenjun; Feinstein, James A; Patel, Neil S; Dai, Dingwei; Feudtner, Chris (2016). "Tall Man lettering and potential prescription errors: A time series analysis of 42 children's hospitals in the USA over 9 years". BMJ Quality & Safety . 25 (4): 233–240. doi: 10.1136/bmjqs-2015-004562 .
  7. 1 2 "Look-Alike Drug Names with Recommended Tall Man Letters". ISMP.org. Institute for Safe Medication Practices. November 20, 2016. Retrieved 2022-01-10. PDF attachment (registration needed, 2011 version)
  8. "TALLman Lettering for Look-Alike/Sound-Alike Drug Names in Canada" (PDF). ismp-canada.org. Retrieved 25 October 2022.